#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Philadelphia chromosome positive Isodicentric chromosome 15 syndrome Juvenile idiopathic arthritis Albright's disease Bile acid synthesis disorder Liposarcoma Cutaneous calcification Duchenne muscular dystrophy gene carrier Plasma cell myeloma Nephrotic syndrome Infantile apnoea Small intestine adenocarcinoma Marginal zone lymphoma recurrent Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Treatment SAPHO syndrome – Basic Information Medulloblastoma recurrent – Trials in Disease VEXAS syndrome Epidermolysis bullosa – Treatment Idiopathic inflammatory myopathy – Diagnostics Chondrosarcoma Fragile X syndrome – Diagnostics Alveolar rhabdomyosarcoma – Treatment Lymphangiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tetrahydrouridine Zolbetuximab Vancomycin Hydrochloride Benzalkonium Chloride ACETYLCARNITINE HYDROCHLORIDE Tisagenlecleucel Nifedipine Ifosfamide Gallium (68Ga) Gozetotide Prilocaine GRAPHITE Dostarlimab POTASSIUM CLAVULANATE Tisotumab Vedotin Cdr132L Sodium Ttf-Ngr Spesolimab Rebisufligene Etisparvovec Imsidolimab Procarbazine More therapies…

    Learn about Your Condition

    Eye pain Small cell carcinoma Colorectal cancer stage II Fungal infection Lupus nephritis Injection site pain Menopause Gastric cancer stage IV Hepatic adenoma Cardiac amyloidosis Peripheral artery angioplasty Anal cancer metastatic Oesophageal food impaction Cold urticaria Endolymphatic hydrops More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Partial lipodystrophy
    Investigated Drugs:
    • Metreleptin
    France Germany Italy

  • Study on the Effects and Safety of Inebilizumab for Patients with Anti-NMDA Receptor Encephalitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Encephalitis autoimmune
    Investigated Drugs:
    • Cetirizine
    • Human Normal Immunoglobulin
    • Cyclophosphamide
    The Netherlands Spain

  • Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tamoxifen
    • Anastrozole
    • Exemestane
    Sweden

  • Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Treprostinil
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polyneuropathy
    Investigated Drugs:
    • D-Camphor
    • Lavender Oil
    • Taxanes
    Germany

  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Humanised Igg1K Monoclonal Antibody Against Interferon Beta
    • Proguanil Hydrochloride
    • Betamethasone
    Belgium Bulgaria France Germany Hungary Italy +4
Previous Page
1 … 537 538 539 540 541 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!